Skip to main content
Clinical Trials/CTRI/2022/02/040002
CTRI/2022/02/040002RecruitingNot Applicable

Revascularisation Delay in ST Elevation Myocardial Infarction (STEMI) Study

Madras Medical College1 site in 1 country300 target enrollmentStarted: July 2, 2022Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
300
Locations
1
Primary Endpoint
Mortality

Study Overview

Brief Summary

Patients with STEMI often do not receive timely reperfusion. This is more common in Low-and middle-income countries.

This happens despite patients reaching revascularisation capable hospitals within the time window.

This observational study aims at identifying the possible reasons behind the reasons for patients getting no or delayed revascularisation in STEMI.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • All patients with Acute STEMI seeking care at our Institution will be eligible for inclusion.

Exclusion Criteria

  • Not willing participants STEMI patients seeking care at our institution as teh first point of medical contact.

Outcomes

Primary Outcomes

Mortality

Time Frame: in hospital and one month

Secondary Outcomes

  • 1. Revascularisation delay(2. No of hospitals visited enroute to our instituion)

Investigators

Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials

Revascularisation Delay in Heart Attack... | Clinical Trial